PAPER Agüera-Ortiz L, Frank-García A, Gil P, Moreno A,
SEARCH RESULTS
329963 RESULTS
PAPER Herrmann N, Black SE, Li A, Lanctôt KL
Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.
Int Psychogeriatr. 2011 May;23(4):539-45. PubMed: 20849673PAPER Takahashi H, Fukumoto H, Maeda R, Terauchi J, Kato K, Miyamoto M
Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats.
Brain Res. 2010 Nov 18;1361:146-56. PubMed: 20849831PAPER Fernandez JW, Rezai-Zadeh K, Obregon D, Tan J
EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP.
FEBS Lett. 2010 Oct 8;584(19):4259-67. PubMed: 20849853PAPER Talboom JS, Engler-Chiurazzi EB, Whiteaker P, Simard AR, Lukas R, Acosta JI, Prokai L, Bimonte-Nelson HA
A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.
Horm Behav. 2010 Nov;58(5):917-28. PubMed: 20849857PAPER Benedict C, Frey WH, Schiöth HB, Schultes B, Born J, Hallschmid M
Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. PubMed: 20849944PAPER Garelick MG, Kennedy BK
TOR on the brain.
Exp Gerontol. 2011 Feb-Mar;46(2-3):155-63. PubMed: 20849946PAPER Cohen E
Countering neurodegeneration by reducing the activity of the insulin/IGF signaling pathway: current knowledge and future prospects.
Exp Gerontol. 2011 Feb-Mar;46(2-3):124-8. PubMed: 20849948PAPER Silver M, Montana G, Nichols TE,
False positives in neuroimaging genetics using voxel-based morphometry data.
Neuroimage. 2011 Jan 15;54(2):992-1000. PubMed: 20849959PAPER Ramirez J, Gibson E, Quddus A, Lobaugh NJ, Feinstein A, Levine B, Scott CJ, Levy-Cooperman N, Gao FQ, Black SE
Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue.
Neuroimage. 2011 Jan 15;54(2):963-73. PubMed: 20849961PAPER Attems J, Yamaguchi H, Saido TC, Thal DR
Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology.
J Neurol Sci. 2010 Dec 15;299(1-2):155-62. PubMed: 20850138PAPER Werring DJ, Gregoire SM, Cipolotti L
Cerebral microbleeds and vascular cognitive impairment.
J Neurol Sci. 2010 Dec 15;299(1-2):131-5. PubMed: 20850134PAPER Zhan ZJ, Yu Q, Wang ZL, Shan WG
Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities.
Bioorg Med Chem Lett. 2010 Nov 1;20(21):6185-7. PubMed: 20850311PAPER Scullion GA, Kendall DA, Marsden CA, Sunter D, Pardon MC
Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
Neuropharmacology. 2011 Feb-Mar;60(2-3):223-34. PubMed: 20850464PAPER Wardlaw JM
Blood-brain barrier and cerebral small vessel disease.
J Neurol Sci. 2010 Dec 15;299(1-2):66-71. PubMed: 20850797Current Filters
No filters selected